2024 Q3 Form 10-K Financial Statement
#000086266824000022 Filed on September 30, 2024
Income Statement
Concept | 2024 Q3 | 2024 Q2 | 2024 |
---|---|---|---|
Revenue | $2.781M | $3.472M | $11.98M |
YoY Change | -5.56% | 10.72% | -1.63% |
Cost Of Revenue | $1.568M | $2.000M | $6.835M |
YoY Change | -4.89% | 19.23% | 2.04% |
Gross Profit | $1.213M | $1.472M | $5.146M |
YoY Change | -6.4% | 0.94% | -6.11% |
Gross Profit Margin | 43.62% | 42.39% | 42.95% |
Selling, General & Admin | $1.099M | $1.161M | $4.562M |
YoY Change | -0.08% | 7.87% | 9.04% |
% of Gross Profit | 90.61% | 78.85% | 88.66% |
Research & Development | $140.9K | $173.0K | $688.2K |
YoY Change | -33.45% | -2.52% | -15.95% |
% of Gross Profit | 11.61% | 11.75% | 13.37% |
Depreciation & Amortization | $10.63K | $19.26K | $46.02K |
YoY Change | -3.64% | 78.66% | 1.8% |
% of Gross Profit | 0.88% | 1.31% | 0.89% |
Operating Expenses | $1.240M | $1.334M | $5.251M |
YoY Change | -5.46% | 6.4% | 4.95% |
Operating Profit | -$26.96K | $138.3K | -$104.5K |
YoY Change | 72.27% | -32.5% | -121.83% |
Interest Expense | -$5.260K | -$3.900K | $20.79K |
YoY Change | -194.77% | -40.28% | -4.85% |
% of Operating Profit | -2.82% | ||
Other Income/Expense, Net | -$5.262K | -$20.79K | |
YoY Change | -5.19% | -4.29% | |
Pretax Income | -$32.22K | $134.4K | -$125.3K |
YoY Change | 51.98% | -32.24% | -127.42% |
Income Tax | $0.00 | $0.00 | $0.00 |
% Of Pretax Income | 0.0% | ||
Net Earnings | -$32.22K | $121.6K | -$125.3K |
YoY Change | 51.99% | 6654.44% | -127.42% |
Net Earnings / Revenue | -1.16% | 3.5% | -1.05% |
Basic Earnings Per Share | -$0.01 | -$0.02 | |
Diluted Earnings Per Share | -$0.01 | $0.02 | -$0.02 |
COMMON SHARES | |||
Basic Shares Outstanding | 7.415M shares | 7.415M shares | 7.415M shares |
Diluted Shares Outstanding | 7.415M shares | 7.415M shares |
Balance Sheet
Concept | 2024 Q3 | 2024 Q2 | 2024 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $229.7K | $209.0K | $209.0K |
YoY Change | -69.16% | -76.5% | -76.5% |
Cash & Equivalents | $486.2K | $209.0K | $209.0K |
Short-Term Investments | |||
Other Short-Term Assets | $224.6K | $194.1K | $450.5K |
YoY Change | -22.37% | -22.3% | -10.98% |
Inventory | $1.806M | $1.613M | $1.613M |
Prepaid Expenses | |||
Receivables | $1.931M | $2.124M | $2.124M |
Other Receivables | $0.00 | $0.00 | $0.00 |
Total Short-Term Assets | $4.448M | $4.397M | $4.397M |
YoY Change | 2.83% | -5.19% | -5.19% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $43.16K | $48.88K | $248.9K |
YoY Change | -6.73% | 43.49% | -53.72% |
Goodwill | |||
YoY Change | |||
Intangibles | |||
YoY Change | |||
Long-Term Investments | |||
YoY Change | |||
Other Assets | $62.79K | $62.79K | $62.79K |
YoY Change | 0.0% | 0.0% | 0.0% |
Total Long-Term Assets | $271.3K | $361.1K | $361.1K |
YoY Change | -55.0% | -46.14% | -46.14% |
TOTAL ASSETS | |||
Total Short-Term Assets | $4.448M | $4.397M | $4.397M |
Total Long-Term Assets | $271.3K | $361.1K | $361.1K |
Total Assets | $4.719M | $4.758M | $4.758M |
YoY Change | -4.25% | -10.36% | -10.36% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $1.396M | $1.357M | $1.357M |
YoY Change | 23.71% | 12.58% | 12.58% |
Accrued Expenses | $589.2K | $588.3K | $867.0K |
YoY Change | -4.32% | -9.76% | -20.75% |
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | -100.0% | ||
Long-Term Debt Due | $41.56K | $37.35K | $37.35K |
YoY Change | 8.6% | -7.07% | -7.07% |
Total Short-Term Liabilities | $2.681M | $2.669M | $2.669M |
YoY Change | 2.94% | -6.45% | -6.45% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $254.5K | $271.3K | $271.3K |
YoY Change | -13.51% | -11.32% | -11.32% |
Other Long-Term Liabilities | $5.810K | $8.070K | $8.070K |
YoY Change | -94.97% | -96.23% | -96.23% |
Total Long-Term Liabilities | $260.3K | $279.4K | $279.4K |
YoY Change | -36.49% | -46.27% | -46.27% |
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $2.681M | $2.669M | $2.669M |
Total Long-Term Liabilities | $260.3K | $279.4K | $279.4K |
Total Liabilities | $2.942M | $2.948M | $2.948M |
YoY Change | -2.42% | -12.59% | -12.59% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$68.58M | -$68.54M | |
YoY Change | 0.2% | 0.18% | |
Common Stock | $7.415K | $7.415K | |
YoY Change | 0.0% | 0.0% | |
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | $1.777M | $1.810M | $1.810M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $4.719M | $4.758M | $4.758M |
YoY Change | -4.25% | -10.36% | -10.36% |
Cashflow Statement
Concept | 2024 Q3 | 2024 Q2 | 2024 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$32.22K | $121.6K | -$125.3K |
YoY Change | 51.99% | 6654.44% | -127.42% |
Depreciation, Depletion And Amortization | $10.63K | $19.26K | $46.02K |
YoY Change | -3.64% | 78.66% | 1.8% |
Cash From Operating Activities | $33.33K | -$339.9K | -$602.8K |
YoY Change | -128.74% | -195.76% | -285.38% |
INVESTING ACTIVITIES | |||
Capital Expenditures | $0.00 | $9.250K | $40.29K |
YoY Change | -100.0% | 502.44% | |
Acquisitions | |||
YoY Change | |||
Other Investing Activities | |||
YoY Change | |||
Cash From Investing Activities | $0.00 | -$9.250K | -$40.29K |
YoY Change | -100.0% | 191.03% | |
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | |||
YoY Change | |||
Debt Paid & Issued, Net | $3.860K | ||
YoY Change | 24.32% | ||
Cash From Financing Activities | -$12.63K | -6.530K | -$37.46K |
YoY Change | 20.1% | -31.41% | 143.68% |
NET CHANGE | |||
Cash From Operating Activities | $33.33K | -339.9K | -$602.8K |
Cash From Investing Activities | $0.00 | -9.250K | -$40.29K |
Cash From Financing Activities | -$12.63K | -6.530K | -$37.46K |
Net Change In Cash | $20.70K | -355.7K | -$680.5K |
YoY Change | -114.29% | -202.96% | -329.95% |
FREE CASH FLOW | |||
Cash From Operating Activities | $33.33K | -$339.9K | -$602.8K |
Capital Expenditures | $0.00 | $9.250K | $40.29K |
Free Cash Flow | $33.33K | -$349.1K | -$643.1K |
YoY Change | -124.82% | -198.36% | -301.93% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2023Q2 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2023Q2 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
35000000 | shares |
CY2023Q2 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
7415329 | shares |
CY2023Q2 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
7415329 | shares |
CY2024 | dei |
Entity File Number
EntityFileNumber
|
0-20127 | |
CY2024 | dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
PA | |
CY2024 | dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
33-0272839 | |
CY2024 | dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
435 Devon Park Drive, Suite 824 | |
CY2024 | dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
Wayne | |
CY2024 | dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
PA | |
CY2024 | dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
19087 | |
CY2024 | dei |
City Area Code
CityAreaCode
|
610 | |
CY2024 | dei |
Local Phone Number
LocalPhoneNumber
|
688-6830 | |
CY2024 | dei |
Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
|
No | |
CY2024 | dei |
Entity Voluntary Filers
EntityVoluntaryFilers
|
No | |
CY2024 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
CY2024 | dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | |
CY2024 | dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | |
CY2024 | dei |
Entity Small Business
EntitySmallBusiness
|
true | |
CY2024 | dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
false | |
CY2024 | dei |
Entity Shell Company
EntityShellCompany
|
false | |
CY2023Q4 | dei |
Entity Public Float
EntityPublicFloat
|
773304 | usd |
CY2024Q3 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
7415329 | shares |
CY2024Q2 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
2124159 | usd |
CY2023Q2 | us-gaap |
Notes Payable To Bank Current
NotesPayableToBankCurrent
|
37087 | usd |
CY2023Q2 | us-gaap |
Secured Debt Current
SecuredDebtCurrent
|
3105 | usd |
CY2023Q2 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
1205510 | usd |
CY2023Q2 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
651978 | usd |
CY2023Q2 | us-gaap |
Interest Payable Current
InterestPayableCurrent
|
112389 | usd |
CY2023Q2 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
329638 | usd |
CY2023Q2 | us-gaap |
Deferred Revenue Current
DeferredRevenueCurrent
|
426227 | usd |
CY2023Q2 | us-gaap |
Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
|
87125 | usd |
CY2023Q2 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
2853059 | usd |
CY2023Q2 | us-gaap |
Other Long Term Notes Payable
OtherLongTermNotesPayable
|
159511 | usd |
CY2023Q2 | us-gaap |
Liabilities Noncurrent
LiabilitiesNoncurrent
|
520049 | usd |
CY2023Q2 | us-gaap |
Liabilities
Liabilities
|
3373108 | usd |
CY2023Q2 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
645000 | usd |
CY2023Q2 | us-gaap |
Common Stock Value
CommonStockValue
|
7415 | usd |
CY2023Q2 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
69702043 | usd |
CY2023Q2 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-68419615 | usd |
CY2023Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
1934843 | usd |
CY2023Q2 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
5307951 | usd |
CY2023 | us-gaap |
Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
|
12180221 | usd |
CY2023 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
6698858 | usd |
CY2023 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
4184051 | usd |
CY2023 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
818769 | usd |
CY2023 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
11701678 | usd |
CY2023 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
478543 | usd |
CY2022Q2 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
593869 | usd |
CY2022Q2 | us-gaap |
Restricted Cash
RestrictedCash
|
256165 | usd |
CY2022Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
850034 | usd |
CY2024Q2 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2024Q2 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
7415329 | shares |
CY2024Q2 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
7415329 | shares |
CY2024Q2 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
CY2024Q2 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
2000000 | shares |
CY2024Q2 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
209033 | usd |
CY2024Q2 | us-gaap |
Restricted Cash Current
RestrictedCashCurrent
|
256422 | usd |
CY2024Q2 | us-gaap |
Accounts Receivable Gross
AccountsReceivableGross
|
2295263 | usd |
CY2024Q2 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
171104 | usd |
CY2024Q2 | us-gaap |
Inventory Net
InventoryNet
|
1613118 | usd |
CY2024Q2 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
194096 | usd |
CY2024Q2 | us-gaap |
Assets Current
AssetsCurrent
|
4396828 | usd |
CY2024Q2 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
48878 | usd |
CY2024Q2 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
199989 | usd |
CY2024Q2 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
49442 | usd |
CY2024Q2 | us-gaap |
Deposits Assets Noncurrent
DepositsAssetsNoncurrent
|
62788 | usd |
CY2024Q2 | us-gaap |
Assets
Assets
|
4757925 | usd |
CY2024Q2 | us-gaap |
Secured Debt Current
SecuredDebtCurrent
|
3172 | usd |
CY2024Q2 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
1357222 | usd |
CY2024Q2 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
588317 | usd |
CY2024Q2 | us-gaap |
Interest Payable Current
InterestPayableCurrent
|
112389 | usd |
CY2024Q2 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
207966 | usd |
CY2024Q2 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
2668939 | usd |
CY2024Q2 | us-gaap |
Other Long Term Notes Payable
OtherLongTermNotesPayable
|
128825 | usd |
CY2023Q2 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
214103 | usd |
CY2024Q2 | us-gaap |
Liabilities Noncurrent
LiabilitiesNoncurrent
|
279404 | usd |
CY2024Q2 | us-gaap |
Liabilities
Liabilities
|
2948343 | usd |
CY2024Q2 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
645000 | usd |
CY2024Q2 | us-gaap |
Common Stock Value
CommonStockValue
|
7415 | usd |
CY2024Q2 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
69702043 | usd |
CY2024Q2 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-68544876 | usd |
CY2024Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
1809582 | usd |
CY2024Q2 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
4757925 | usd |
CY2024 | us-gaap |
Interest Expense
InterestExpense
|
20785 | usd |
CY2023Q2 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
889674 | usd |
CY2023Q2 | us-gaap |
Restricted Cash
RestrictedCash
|
256293 | usd |
CY2023Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
1145967 | usd |
CY2023Q2 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
153878 | usd |
CY2023Q2 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
153878 | usd |
CY2024 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0000862668 | |
CY2024 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2024 | |
CY2024 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
FY | |
CY2024 | dei |
Document Annual Report
DocumentAnnualReport
|
true | |
CY2024 | dei |
Amendment Flag
AmendmentFlag
|
false | |
CY2024Q2 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
35000000 | shares |
CY2023Q2 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
CY2023Q2 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
2000000 | shares |
CY2024Q2 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
2000000 | shares |
CY2023Q2 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
2000000 | shares |
CY2024 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2024-06-30 | |
CY2024 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--06-30 | |
CY2024 | dei |
Entity Registrant Name
EntityRegistrantName
|
Escalon Medical Corp. | |
CY2024 | dei |
Auditor Name
AuditorName
|
Marcum LLP | |
CY2024 | dei |
Auditor Location
AuditorLocation
|
Marlton, New Jersey | |
CY2023Q2 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
889674 | usd |
CY2023Q2 | us-gaap |
Restricted Cash Current
RestrictedCashCurrent
|
256293 | usd |
CY2023Q2 | us-gaap |
Accounts Receivable Gross
AccountsReceivableGross
|
1807599 | usd |
CY2023Q2 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
153878 | usd |
CY2023Q2 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
1653721 | usd |
CY2023Q2 | us-gaap |
Inventory Net
InventoryNet
|
1587989 | usd |
CY2023Q2 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
249790 | usd |
CY2023Q2 | us-gaap |
Assets Current
AssetsCurrent
|
4637467 | usd |
CY2023Q2 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
34064 | usd |
CY2023Q2 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
503647 | usd |
CY2023Q2 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
69986 | usd |
CY2023Q2 | us-gaap |
Deposits Assets Noncurrent
DepositsAssetsNoncurrent
|
62787 | usd |
CY2023Q2 | us-gaap |
Assets
Assets
|
5307951 | usd |
CY2024Q2 | us-gaap |
Notes Payable To Bank Current
NotesPayableToBankCurrent
|
34177 | usd |
CY2024 | us-gaap |
Operating Lease Expense
OperatingLeaseExpense
|
339941 | usd |
CY2023 | us-gaap |
Operating Lease Expense
OperatingLeaseExpense
|
341136 | usd |
CY2024Q2 | us-gaap |
Deferred Revenue Current
DeferredRevenueCurrent
|
280004 | usd |
CY2024Q2 | us-gaap |
Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
|
85692 | usd |
CY2024 | us-gaap |
Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
|
11981509 | usd |
CY2023 | us-gaap |
Interest Expense
InterestExpense
|
21717 | usd |
CY2023 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-21717 | usd |
CY2023 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | usd |
CY2023 | us-gaap |
Net Income Loss
NetIncomeLoss
|
456826 | usd |
CY2024 | us-gaap |
Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
|
51672 | usd |
CY2023 | us-gaap |
Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
|
51600 | usd |
CY2024 | us-gaap |
Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
|
0 | usd |
CY2023 | us-gaap |
Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
|
183695 | usd |
CY2024 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-176933 | usd |
CY2023 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
221531 | usd |
CY2024 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.02 | |
CY2023 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.03 | |
CY2024 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.02 | |
CY2023 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.03 | |
CY2024 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
7415329 | shares |
CY2023 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
7415329 | shares |
CY2024 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
7415329 | shares |
CY2023 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
13564202 | shares |
CY2023Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
1934843 | usd |
CY2024 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-125261 | usd |
CY2024Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
1809582 | usd |
CY2022Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
1478017 | usd |
CY2023 | us-gaap |
Net Income Loss
NetIncomeLoss
|
456826 | usd |
CY2023Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
1934843 | usd |
CY2024 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-125261 | usd |
CY2023 | us-gaap |
Net Income Loss
NetIncomeLoss
|
456826 | usd |
CY2024 | us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
-16420 | usd |
CY2023 | us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
118000 | usd |
CY2024 | esmc |
Increase In Inventory Reserve
IncreaseInInventoryReserve
|
-653 | usd |
CY2023 | esmc |
Increase In Inventory Reserve
IncreaseInInventoryReserve
|
60000 | usd |
CY2024 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
46015 | usd |
CY2023 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
45202 | usd |
CY2024 | us-gaap |
Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
|
303658 | usd |
CY2023 | us-gaap |
Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
|
289557 | usd |
CY2024 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
454018 | usd |
CY2023 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
229971 | usd |
CY2024 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
24476 | usd |
CY2023 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
44034 | usd |
CY2024 | us-gaap |
Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
|
-55694 | usd |
CY2023 | us-gaap |
Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
|
59746 | usd |
CY2024 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
151712 | usd |
CY2023 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
193059 | usd |
CY2024 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
-63661 | usd |
CY2023 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
-250018 | usd |
CY2024 | us-gaap |
Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
|
-327704 | usd |
CY2023 | us-gaap |
Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
|
-304737 | usd |
CY2024 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
-146223 | usd |
CY2023 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
93844 | usd |
CY2024 | us-gaap |
Increase Decrease In Other Deferred Liability
IncreaseDecreaseInOtherDeferredLiability
|
-1434 | usd |
CY2023 | us-gaap |
Increase Decrease In Other Deferred Liability
IncreaseDecreaseInOtherDeferredLiability
|
-42836 | usd |
CY2024 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-602771 | usd |
CY2023 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
325146 | usd |
CY2024 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
40285 | usd |
CY2023 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
6687 | usd |
CY2024 | us-gaap |
Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
|
0 | usd |
CY2023 | us-gaap |
Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
|
7155 | usd |
CY2024 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-40285 | usd |
CY2023 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-13842 | usd |
CY2024 | us-gaap |
Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
|
3860 | usd |
CY2023 | us-gaap |
Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
|
3105 | usd |
CY2024 | us-gaap |
Repayments Of Notes Payable
RepaymentsOfNotesPayable
|
33596 | usd |
CY2023 | us-gaap |
Repayments Of Notes Payable
RepaymentsOfNotesPayable
|
12266 | usd |
CY2024 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-37456 | usd |
CY2023 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-15371 | usd |
CY2024 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-680512 | usd |
CY2023 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
295933 | usd |
CY2023Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
1145967 | usd |
CY2023Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
1145967 | usd |
CY2024Q2 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
209033 | usd |
CY2024Q2 | us-gaap |
Restricted Cash
RestrictedCash
|
256422 | usd |
CY2023Q2 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
889674 | usd |
CY2023Q2 | us-gaap |
Restricted Cash
RestrictedCash
|
256293 | usd |
CY2023Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
1145967 | usd |
CY2024 | us-gaap |
Interest Paid Net
InterestPaidNet
|
20991 | usd |
CY2023 | us-gaap |
Interest Paid Net
InterestPaidNet
|
22281 | usd |
CY2024 | us-gaap |
Nature Of Operations
NatureOfOperations
|
Escalon Medical Corp. ("Escalon" or "Company") is a Pennsylvania corporation initially incorporated in California in 1987, and reincorporated in Pennsylvania in November 2001. Within this document, the “Company” collectively shall mean Escalon, which includes its division called "Trek" and its wholly owned subsidiaries: Sonomed, Inc. (“Sonomed”), Escalon Digital Solutions, Inc. (“EMI”), and Sonomed IP Holdings, Inc. <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company operates in the healthcare market, specializing in the development, manufacture, marketing and distribution of medical devices and pharmaceuticals in the area of ophthalmology. The Company and its products are subject to regulation and inspection by the United States Food and Drug Administration (the “FDA”). The FDA and other government authorities require extensive testing of new products prior to sale and have jurisdiction over the safety, efficacy and manufacture of products, as well as product labeling and marketing.</span></div> The Company’s common stock trades on the OTCQB Market under the symbol “ESMC.” | |
CY2024 | us-gaap |
Short Term Lease Payments
ShortTermLeasePayments
|
350413 | usd |
CY2023 | us-gaap |
Short Term Lease Payments
ShortTermLeasePayments
|
343241 | usd |
CY2024 | us-gaap |
Short Term Lease Payments
ShortTermLeasePayments
|
350413 | usd |
CY2023 | us-gaap |
Short Term Lease Payments
ShortTermLeasePayments
|
343241 | usd |
CY2024Q2 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
199989 | usd |
CY2023Q2 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
503647 | usd |
CY2024Q2 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
207966 | usd |
CY2023Q2 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
329638 | usd |
CY2024 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America ("US GAAP") requires management to make estimates and assumptions that impact the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.</span></div> | |
CY2024 | esmc |
Maximum Maturity Of Highly Liquid Investments Period
MaximumMaturityOfHighlyLiquidInvestmentsPeriod
|
P90D | |
CY2024Q2 | us-gaap |
Restricted Cash
RestrictedCash
|
256000 | usd |
CY2022Q2 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
236349 | usd |
CY2024 | us-gaap |
Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
|
37546 | usd |
CY2023 | us-gaap |
Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
|
4600 | usd |
CY2024 | us-gaap |
Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
|
20320 | usd |
CY2023 | us-gaap |
Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
|
87071 | usd |
CY2024Q2 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
171104 | usd |
CY2023Q2 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
153878 | usd |
CY2023Q2 | us-gaap |
Inventory Raw Materials
InventoryRawMaterials
|
882093 | usd |
CY2023Q2 | us-gaap |
Inventory Work In Process
InventoryWorkInProcess
|
85575 | usd |
CY2023Q2 | us-gaap |
Inventory Finished Goods
InventoryFinishedGoods
|
880717 | usd |
CY2023Q2 | us-gaap |
Inventory Gross
InventoryGross
|
1848385 | usd |
CY2024Q2 | us-gaap |
Inventory Valuation Reserves
InventoryValuationReserves
|
259743 | usd |
CY2023Q2 | us-gaap |
Inventory Valuation Reserves
InventoryValuationReserves
|
260396 | usd |
CY2024Q2 | us-gaap |
Inventory Net
InventoryNet
|
1613118 | usd |
CY2023Q2 | us-gaap |
Inventory Net
InventoryNet
|
1587989 | usd |
CY2024Q2 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
994864 | usd |
CY2024Q2 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
8071 | usd |
CY2023Q2 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
214103 | usd |
CY2023Q2 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
945332 | usd |
CY2024Q2 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
945986 | usd |
CY2023Q2 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
911268 | usd |
CY2024Q2 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
48878 | usd |
CY2023Q2 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
34064 | usd |
CY2023Q2 | us-gaap |
Deferred Revenue
DeferredRevenue
|
426000 | usd |
CY2022Q2 | us-gaap |
Deferred Revenue
DeferredRevenue
|
333000 | usd |
CY2024 | us-gaap |
Deferred Revenue Additions
DeferredRevenueAdditions
|
692000 | usd |
CY2023 | us-gaap |
Deferred Revenue Additions
DeferredRevenueAdditions
|
717000 | usd |
CY2024 | us-gaap |
Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
|
838000 | usd |
CY2023 | us-gaap |
Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
|
624000 | usd |
CY2024Q2 | us-gaap |
Deferred Revenue
DeferredRevenue
|
280000 | usd |
CY2023Q2 | us-gaap |
Deferred Revenue
DeferredRevenue
|
426000 | usd |
CY2024 | esmc |
Us Gaap Deferred Revenue Revenue Recognized Included Within Prior Period Deferred Revenue
UsGaap_DeferredRevenueRevenueRecognizedIncludedWithinPriorPeriodDeferredRevenue
|
289000 | usd |
CY2023 | esmc |
Us Gaap Deferred Revenue Revenue Recognized Included Within Prior Period Deferred Revenue
UsGaap_DeferredRevenueRevenueRecognizedIncludedWithinPriorPeriodDeferredRevenue
|
315000 | usd |
CY2024 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-125261 | usd |
CY2023 | us-gaap |
Net Income Loss
NetIncomeLoss
|
456826 | usd |
CY2024 | us-gaap |
Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
|
51672 | usd |
CY2023 | us-gaap |
Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
|
51600 | usd |
CY2024 | us-gaap |
Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
|
0 | usd |
CY2023 | us-gaap |
Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
|
183695 | usd |
CY2024 | us-gaap |
Net Income Loss From Continuing Operations Available To Common Shareholders Basic
NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic
|
-176933 | usd |
CY2023 | us-gaap |
Net Income Loss From Continuing Operations Available To Common Shareholders Basic
NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic
|
221531 | usd |
CY2024 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-125261 | usd |
CY2023 | us-gaap |
Net Income Loss
NetIncomeLoss
|
456826 | usd |
CY2024 | us-gaap |
Convertible Preferred Dividends Net Of Tax
ConvertiblePreferredDividendsNetOfTax
|
51672 | usd |
CY2023 | us-gaap |
Dilutive Securities Effect On Basic Earnings Per Share Other
DilutiveSecuritiesEffectOnBasicEarningsPerShareOther
|
51600 | usd |
CY2024 | us-gaap |
Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
|
-176933 | usd |
CY2023 | us-gaap |
Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
|
405226 | usd |
CY2024 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
7415329 | shares |
CY2023 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
7415329 | shares |
CY2024 | us-gaap |
Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
|
0 | shares |
CY2023 | us-gaap |
Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
|
6148873 | shares |
CY2024 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
7415329 | shares |
CY2023 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
13564202 | shares |
CY2024 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.02 | |
CY2023 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.03 | |
CY2024 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.02 | |
CY2023 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.03 | |
CY2024 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
6514353 | shares |
CY2023 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
157000 | shares |
CY2024Q2 | esmc |
Finitelivedtangibleassetsaccumulatedimpairment
Finitelivedtangibleassetsaccumulatedimpairment
|
0 | usd |
CY2024Q2 | esmc |
Finitelivedtangibleassetsaccumulatedimpairment
Finitelivedtangibleassetsaccumulatedimpairment
|
0 | usd |
CY2023Q2 | esmc |
Finitelivedtangibleassetsaccumulatedimpairment
Finitelivedtangibleassetsaccumulatedimpairment
|
0 | usd |
CY2023Q2 | esmc |
Finitelivedtangibleassetsaccumulatedimpairment
Finitelivedtangibleassetsaccumulatedimpairment
|
0 | usd |
CY2024Q2 | us-gaap |
Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
|
212671 | usd |
CY2024Q2 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
|
4269 | usd |
CY2024Q2 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
|
1541 | usd |
CY2024Q2 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
|
1541 | usd |
CY2024Q2 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
|
1541 | usd |
CY2024Q2 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
472388 | usd |
CY2023Q2 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
470896 | usd |
CY2024Q2 | us-gaap |
Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
|
32078 | usd |
CY2023Q2 | us-gaap |
Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
|
32078 | usd |
CY2024Q2 | us-gaap |
Sales And Excise Tax Payable Current And Noncurrent
SalesAndExciseTaxPayableCurrentAndNoncurrent
|
41646 | usd |
CY2023Q2 | us-gaap |
Sales And Excise Tax Payable Current And Noncurrent
SalesAndExciseTaxPayableCurrentAndNoncurrent
|
101103 | usd |
CY2024Q2 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
42205 | usd |
CY2023Q2 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
47901 | usd |
CY2024Q2 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
588317 | usd |
CY2023Q2 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
651978 | usd |
CY2024Q2 | us-gaap |
Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
|
385 | usd |
CY2024Q2 | us-gaap |
Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
|
221948 | usd |
CY2024Q2 | us-gaap |
Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
|
5911 | usd |
CY2024Q2 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
216037 | usd |
CY2024Q2 | us-gaap |
Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
|
P0Y9M21D | |
CY2023Q2 | us-gaap |
Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
|
P1Y8M1D | |
CY2024Q2 | us-gaap |
Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
|
0.0579 | |
CY2024Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
21000 | shares |
CY2023Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
157000 | shares |
CY2023Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
1.47 | |
CY2022Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
157000 | shares |
CY2022Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
1.47 | |
CY2024 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
0 | shares |
CY2024 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
0 | |
CY2023 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
0 | shares |
CY2023 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
0 | |
CY2024 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
|
0 | usd |
CY2024 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
0 | |
CY2023 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
|
0 | usd |
CY2023 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
0 | |
CY2024 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
|
136000 | shares |
CY2024 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
|
1.57 | |
CY2023 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
|
0 | shares |
CY2023 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
|
0 | |
CY2024Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
21000 | shares |
CY2024Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
0.79 | |
CY2023Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
157000 | shares |
CY2023Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
1.47 | |
CY2024Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
21000 | shares |
CY2024Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
|
0.79 | |
CY2023Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
157000 | shares |
CY2023Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
|
1.47 | |
CY2024Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
21000 | shares |
CY2024Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
21000 | shares |
CY2023 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
0 | |
CY2024 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
0 | |
CY2024 | us-gaap |
Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
|
-49877 | usd |
CY2023 | us-gaap |
Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
|
64399 | usd |
CY2024 | us-gaap |
Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
|
-3482 | usd |
CY2023 | us-gaap |
Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
|
30666 | usd |
CY2024 | us-gaap |
Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
|
53359 | usd |
CY2023 | us-gaap |
Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
|
-95065 | usd |
CY2024 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.2100 | |
CY2023 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.2100 | |
CY2024 | us-gaap |
Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
|
0.0417 | |
CY2023 | us-gaap |
Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
|
0.0000 | |
CY2024 | us-gaap |
Effective Income Tax Rate Reconciliation Deductions
EffectiveIncomeTaxRateReconciliationDeductions
|
-0.0587 | |
CY2023 | us-gaap |
Effective Income Tax Rate Reconciliation Deductions
EffectiveIncomeTaxRateReconciliationDeductions
|
0.0000 | |
CY2024 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
|
0.0164 | |
CY2023 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
|
0.0000 | |
CY2024 | us-gaap |
Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
|
0.2436 | |
CY2023 | us-gaap |
Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
|
0.0000 | |
CY2024 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
-0.4260 | |
CY2023 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
-0.2100 | |
CY2024 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.0000 | |
CY2023 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.0000 | |
CY2024Q2 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
7136971 | usd |
CY2023Q2 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
7028242 | usd |
CY2024 | us-gaap |
Deferred Tax Expense From Stock Options Exercised
DeferredTaxExpenseFromStockOptionsExercised
|
3306 | usd |
CY2023 | us-gaap |
Deferred Tax Expense From Stock Options Exercised
DeferredTaxExpenseFromStockOptionsExercised
|
33877 | usd |
CY2024Q2 | us-gaap |
Deferred Tax Assets Regulatory Assets And Liabilities
DeferredTaxAssetsRegulatoryAssetsAndLiabilities
|
44930 | usd |
CY2023Q2 | us-gaap |
Deferred Tax Assets Regulatory Assets And Liabilities
DeferredTaxAssetsRegulatoryAssetsAndLiabilities
|
155111 | usd |
CY2024Q2 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
|
38440 | usd |
CY2023Q2 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
|
47391 | usd |
CY2024Q2 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits
|
54631 | usd |
CY2023Q2 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits
|
70084 | usd |
CY2024Q2 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves
|
58354 | usd |
CY2023Q2 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves
|
107914 | usd |
CY2024Q2 | us-gaap |
Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
|
323570 | usd |
CY2023Q2 | us-gaap |
Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
|
290921 | usd |
CY2024Q2 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Warranty Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves
|
7206 | usd |
CY2023Q2 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Warranty Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves
|
9879 | usd |
CY2024Q2 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
7667408 | usd |
CY2023Q2 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
7743419 | usd |
CY2024Q2 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
7607765 | usd |
CY2023Q2 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
7554406 | usd |
CY2024Q2 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
59643 | usd |
CY2023Q2 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
189013 | usd |
CY2024Q2 | us-gaap |
Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
|
11108 | usd |
CY2023Q2 | us-gaap |
Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
|
0.0569 | |
CY2023Q2 | us-gaap |
Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
|
189013 | usd |
CY2024Q2 | us-gaap |
Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
|
48535 | usd |
CY2023Q2 | us-gaap |
Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
|
167459 | usd |
CY2024Q2 | us-gaap |
Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
|
59643 | usd |
CY2023Q2 | us-gaap |
Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
|
189013 | usd |
CY2024Q2 | us-gaap |
Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
|
0 | usd |
CY2023Q2 | us-gaap |
Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
|
0 | usd |
CY2024Q2 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
7607765 | usd |
CY2024 | us-gaap |
Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
|
53359 | usd |
CY2023 | us-gaap |
Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
|
-95065 | usd |
CY2024 | us-gaap |
Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
|
645000 | usd |
CY2024Q2 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
2000000 | shares |
CY2024Q2 | us-gaap |
Interest Payable Current
InterestPayableCurrent
|
112389 | usd |
CY2024 | us-gaap |
Common Stock Voting Rights
CommonStockVotingRights
|
77.81 | |
CY2024Q2 | us-gaap |
Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
|
2.15 | shares |
CY2024 | us-gaap |
Common Stock Conversion Basis
CommonStockConversionBasis
|
4,300,000 | |
CY2024Q2 | esmc |
Convertible Preferred Stock Percentage Of Outstanding Shares Of Common Stock Upon Conversion
ConvertiblePreferredStockPercentageOfOutstandingSharesOfCommonStockUponConversion
|
0.3670 | |
CY2022Q2 | us-gaap |
Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
|
0.0258 | |
CY2024 | us-gaap |
Preferred Stock Amount Of Preferred Dividends In Arrears
PreferredStockAmountOfPreferredDividendsInArrears
|
329003 | usd |
CY2024Q2 | us-gaap |
Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
|
0.1645 | |
CY2023 | us-gaap |
Preferred Stock Amount Of Preferred Dividends In Arrears
PreferredStockAmountOfPreferredDividendsInArrears
|
277331 | usd |
CY2023Q2 | us-gaap |
Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
|
0.1387 | |
CY2023 | us-gaap |
Concentration Risk Supplier
ConcentrationRiskSupplier
|
two | |
CY2024 | us-gaap |
Operating Lease Expense
OperatingLeaseExpense
|
339941 | usd |
CY2023 | us-gaap |
Operating Lease Expense
OperatingLeaseExpense
|
341136 | usd |
CY2024 | dei |
Auditor Firm
AuditorFirmId
|
688 |